The FDA announced on Feb. 7, 2018, that Pfizer Inc. is recalling Hydromorphone, Hydrochloride, Injection, USP CII vials due to non-sterility risks from cracked or empty containers. The agency classified the recall as Class I.
How to tell if you have it
- Brand: Pfizer
- Product: Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation
- NDC: 0409-2634-01
- Lot: 71330DD EXP. 11/1/2018
The hazard
The recall addresses confirmed customer complaints of glass product container vials that may be empty or cracked, posing a non-sterility risk.
Context
GovInfoNow's records show Pfizer Inc. has 71 other recalls on record since Nov. 26, 2012. Recent Pfizer recalls include an Aug. 4, 2025, Epinephrine Vial recall for lack of sterility assurance and a July 10, 2025, Bicillin L-A Injectable Suspension recall for particulate risk. Other recent recalls of similar products include a Sept. 4, 2026, Pfizer Dopamine HCl Inj Recall for lack of sterility risk and an Aug. 11, 2026, American Regent Epinephrine Injection Recall for particulate matter risk.